BACKGROUND: Benign breast disease and high breast density are prevalent, strong risk factors for breast cancer. Women with both risk factors may be at very high risk. METHODS: We included 42818 women participating in the Breast Cancer Surveillance Consortium who had no prior diagnosis of breast cancer and had undergone at least one benign breast biopsy and mammogram; 1359 women developed incident breast cancer in 6.1 years of follow-up (78.1% invasive, 21.9% ductal carcinoma in situ). We calculated hazard ratios (HRs) using Cox regression analysis. The referent group was women with nonproliferative changes and average density. All P values are two-sided. RESULTS: Benign breast disease and breast density were independently associated with breast cancer. The combination of atypical hyperplasia and very high density was uncommon (0.6% of biopsies) but was associated with the highest risk for breast cancer (HR = 5.34; 95% confidence interval [CI] = 3.52 to 8.09, P < .001). Proliferative disease without atypia (25.6% of biopsies) was associated with elevated risk that varied little across levels of density: average (HR = 1.37; 95% CI = 1.11 to 1.69, P = .003), high (HR = 2.02; 95% CI = 1.68 to 2.44, P < .001), or very high (HR = 2.05; 95% CI = 1.54 to 2.72, P < .001). Low breast density (4.5% of biopsies) was associated with low risk (HRs <1) for all benign pathology diagnoses. CONCLUSIONS: Women with high breast density and proliferative benign breast disease are at very high risk for future breast cancer. Women with low breast density are at low risk, regardless of their benign pathologic diagnosis.
BACKGROUND:Benign breast disease and high breast density are prevalent, strong risk factors for breast cancer. Women with both risk factors may be at very high risk. METHODS: We included 42818 women participating in the Breast Cancer Surveillance Consortium who had no prior diagnosis of breast cancer and had undergone at least one benign breast biopsy and mammogram; 1359 women developed incident breast cancer in 6.1 years of follow-up (78.1% invasive, 21.9% ductal carcinoma in situ). We calculated hazard ratios (HRs) using Cox regression analysis. The referent group was women with nonproliferative changes and average density. All P values are two-sided. RESULTS:Benign breast disease and breast density were independently associated with breast cancer. The combination of atypical hyperplasia and very high density was uncommon (0.6% of biopsies) but was associated with the highest risk for breast cancer (HR = 5.34; 95% confidence interval [CI] = 3.52 to 8.09, P < .001). Proliferative disease without atypia (25.6% of biopsies) was associated with elevated risk that varied little across levels of density: average (HR = 1.37; 95% CI = 1.11 to 1.69, P = .003), high (HR = 2.02; 95% CI = 1.68 to 2.44, P < .001), or very high (HR = 2.05; 95% CI = 1.54 to 2.72, P < .001). Low breast density (4.5% of biopsies) was associated with low risk (HRs <1) for all benign pathology diagnoses. CONCLUSIONS:Women with high breast density and proliferative benign breast disease are at very high risk for future breast cancer. Women with low breast density are at low risk, regardless of their benign pathologic diagnosis.
Authors: Erika A Waters; Timothy S McNeel; Worta McCaskill Stevens; Andrew N Freedman Journal: Breast Cancer Res Treat Date: 2012-05-24 Impact factor: 4.872
Authors: C Byrne; C Schairer; L A Brinton; J Wolfe; N Parekh; M Salane; C Carter; R Hoover Journal: Cancer Causes Control Date: 2001-02 Impact factor: 2.506
Authors: John T Brinton; Lora D Barke; Mary E Freivogel; Stacy Jackson; Colin I O'Donnell; Deborah H Glueck Journal: Acad Radiol Date: 2011-11-03 Impact factor: 3.173
Authors: Nicolien T van Ravesteyn; Diana L Miglioretti; Natasha K Stout; Sandra J Lee; Clyde B Schechter; Diana S M Buist; Hui Huang; Eveline A M Heijnsdijk; Amy Trentham-Dietz; Oguzhan Alagoz; Aimee M Near; Karla Kerlikowske; Heidi D Nelson; Jeanne S Mandelblatt; Harry J de Koning Journal: Ann Intern Med Date: 2012-05-01 Impact factor: 25.391
Authors: David L Page; Peggy A Schuyler; William D Dupont; Roy A Jensen; W Dale Plummer; Jean F Simpson Journal: Lancet Date: 2003-01-11 Impact factor: 79.321
Authors: Jennifer A Harvey; Charlotte C Gard; Diana L Miglioretti; Bonnie C Yankaskas; Karla Kerlikowske; Diana S M Buist; Berta A Geller; Tracy L Onega Journal: Radiology Date: 2012-12-18 Impact factor: 11.105
Authors: Jeanne S Mandelblatt; Natasha K Stout; Clyde B Schechter; Jeroen J van den Broek; Diana L Miglioretti; Martin Krapcho; Amy Trentham-Dietz; Diego Munoz; Sandra J Lee; Donald A Berry; Nicolien T van Ravesteyn; Oguzhan Alagoz; Karla Kerlikowske; Anna N A Tosteson; Aimee M Near; Amanda Hoeffken; Yaojen Chang; Eveline A Heijnsdijk; Gary Chisholm; Xuelin Huang; Hui Huang; Mehmet Ali Ergun; Ronald Gangnon; Brian L Sprague; Sylvia Plevritis; Eric Feuer; Harry J de Koning; Kathleen A Cronin Journal: Ann Intern Med Date: 2016-01-12 Impact factor: 25.391
Authors: Kathy A Toy; Rajeshwari R Valiathan; Fernando Núñez; Kelley M Kidwell; Maria E Gonzalez; Rafael Fridman; Celina G Kleer Journal: Breast Cancer Res Treat Date: 2015-02-10 Impact factor: 4.872
Authors: Catherine S Berkey; Rulla M Tamimi; Walter C Willett; Bernard Rosner; Martha Hickey; Adetunji T Toriola; A Lindsay Frazier; Graham A Colditz Journal: Breast Cancer Res Treat Date: 2019-06-20 Impact factor: 4.872
Authors: Diana L Miglioretti; Linn Abraham; Christoph I Lee; Diana S M Buist; Sally D Herschorn; Brian L Sprague; Louise M Henderson; Anna N A Tosteson; Karla Kerlikowske Journal: Radiology Date: 2019-02-26 Impact factor: 11.105
Authors: Kenyon C Bolton; John L Mace; Pamela M Vacek; Sally D Herschorn; Ted A James; Jeffrey A Tice; Karla Kerlikowske; Berta M Geller; Donald L Weaver; Brian L Sprague Journal: J Natl Cancer Inst Date: 2014-06-23 Impact factor: 13.506
Authors: Audrey J Gaskins; Ana Pereira; Daiana Quintiliano; John A Shepherd; Ricardo Uauy; Camila Corvalán; Karin B Michels Journal: Am J Clin Nutr Date: 2017-04-05 Impact factor: 7.045
Authors: Nehmat Houssami; Linn A Abraham; Tracy Onega; Laura C Collins; Brian L Sprague; Deirdre A Hill; Diana L Miglioretti Journal: Breast Cancer Res Treat Date: 2014-05-07 Impact factor: 4.872
Authors: Jeffrey A Tice; Diana L Miglioretti; Chin-Shang Li; Celine M Vachon; Charlotte C Gard; Karla Kerlikowske Journal: J Clin Oncol Date: 2015-08-17 Impact factor: 44.544